Merck & Co. has agreed to pay more than $671 million to settle a pair ofwhistleblower lawsuits that claimed the company used improper marketingtactics, including kickbacks to doctors, to encourage them to write moreprescriptions for its most profitable drugs, like Vioxx, Zocor andSingulair.

The two settlements were announced by federal prosecutors inPhiladelphia and New Orleans.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]